Stride - LRN Stock Forecast, Price & News

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stride in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" LRN shares.
View LRN analyst ratings or view top-rated stocks.

3 analysts have issued twelve-month target prices for Stride's stock. Their LRN share price forecasts range from $46.00 to $50.00. On average, they expect the company's stock price to reach $48.00 in the next twelve months. This suggests a possible upside of 22.3% from the stock's current price.
View analysts price targets for LRN or view top-rated stocks among Wall Street analysts.

Stride's stock was trading at $31.28 at the beginning of the year. Since then, LRN shares have increased by 25.5% and is now trading at $39.25.
View the best growth stocks for 2023 here.

Stride saw a drop in short interest in February. As of February 28th, there was short interest totaling 4,140,000 shares, a drop of 10.6% from the February 13th total of 4,630,000 shares. Based on an average daily trading volume, of 573,600 shares, the days-to-cover ratio is currently 7.2 days. Currently, 10.2% of the company's stock are sold short.
View Stride's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 18th 2023.
View our LRN earnings forecast.

Stride, Inc. (NYSE:LRN) posted its earnings results on Tuesday, January, 24th. The company reported $1.19 EPS for the quarter, beating the consensus estimate of $1.07 by $0.12. The business earned $458.44 million during the quarter, compared to analysts' expectations of $443.23 million. Stride had a trailing twelve-month return on equity of 12.30% and a net margin of 5.63%. The business's revenue for the quarter was up 11.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.00 EPS.

ETFs with the largest weight of Stride (NYSE:LRN) stock in their portfolio include Global X Education ETF (EDUT), Invesco S&P SmallCap Consumer Discretionary ETF (PSCD), Pacer US Small Cap Cash Cows 100 ETF (CALF), Invesco S&P SmallCap 600 Pure Growth ETF (RZG), Distillate Small/Mid Cash Flow ETF (DSMC), iShares US Small Cap Value Factor ETF (SVAL), Global X Millennial Consumer ETF (MILN) and ETC 6 Meridian Low Beta Equity Strategy ETF (SIXL).

Stride issued an update on its third quarter 2023 earnings guidance on Tuesday, January, 24th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $445.00 million-$465.00 million, compared to the consensus revenue estimate of $436.30 million.

83 employees have rated Stride Chief Executive Officer Nate Davis on Glassdoor.com. Nate Davis has an approval rating of 65% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Stride investors own include AbbVie (ABBV), Advanced Micro Devices (AMD), Pfizer (PFE), NVIDIA (NVDA), QUALCOMM (QCOM), Shopify (SHOP), Chegg (CHGG), PayPal (PYPL), Cisco Systems (CSCO) and JD.com (JD).

Stride trades on the New York Stock Exchange (NYSE) under the ticker symbol "LRN."

Shares of LRN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of LRN stock can currently be purchased for approximately $39.25.

Stride (NYSE:LRN) has a market capitalization of $1.69 billion and generates $1.69 billion in revenue each year. The company earns $107.13 million in net income (profit) each year or $2.33 on an earnings per share basis.

The company employs 7,500 workers across the globe.

Stride's mailing address is 2300 Corporate Park Drive, Herndon VA, 20171. The official website for the company is www.k12.com. The company can be reached via phone at (703) 483-7000, via email at mkraft@k12.com, or via fax at 703-483-7330.